17.75
-0.13 (-0.73%)
| Penutupan Terdahulu | 17.88 |
| Buka | 17.73 |
| Jumlah Dagangan | 3,313 |
| Purata Dagangan (3B) | 8,990 |
| Modal Pasaran | 227,469,792 |
| Harga / Pendapatan (P/E TTM) | 14.67 |
| Harga / Jualan (P/S) | 4.66 |
| Harga / Buku (P/B) | 0.820 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Aug 2023 - 14 Aug 2023 |
| Margin Keuntungan | 50.30% |
| Margin Operasi (TTM) | 66.68% |
| EPS Cair (TTM) | 1.41 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 153.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 869.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.00% |
| Nisbah Semasa (MRQ) | 45.85 |
| Aliran Tunai Operasi (OCF TTM) | 26.90 M |
| Pulangan Atas Aset (ROA TTM) | 5.37% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.13% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Asset Management (US) | Bercampur | Bercampur |
| Asset Management (Global) | Bercampur | Bercampur | |
| Stok | SWK Holdings Corporation | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | 0.06 |
|
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |
|
| Sektor | Financial Services |
| Industri | Asset Management |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 6.38% |
| % Dimiliki oleh Institusi | 87.34% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |